Matches in Nanopublications for { ?s ?p "[In summary, our results suggest that different BCR signaling inhibitors redistribute CLL cells from lymph nodes into the blood through distinct mechanisms: idelalisib actively promotes egress by upregulating S1PR1, whereas fostamatinib and ibrutinib may reduce CLL cell entry and retention by suppressing chemokine-induced integrin activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- NP1259259.RAFxAOe-ggvym9_UwVDX-XY5tGKo-zMa9WEshS4z1Sac8130_assertion description "[In summary, our results suggest that different BCR signaling inhibitors redistribute CLL cells from lymph nodes into the blood through distinct mechanisms: idelalisib actively promotes egress by upregulating S1PR1, whereas fostamatinib and ibrutinib may reduce CLL cell entry and retention by suppressing chemokine-induced integrin activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259259.RAFxAOe-ggvym9_UwVDX-XY5tGKo-zMa9WEshS4z1Sac8130_provenance.